DOSSIER · 13F-HR · Q1 2026

Eversept Partners, LP

$1.9B in tracked AUM across 120 positions as of Q1 2026.

EP
CIK 0001697013 · last filed Mar 31, 2026
Total AUM
$1.9B
as of Q1 2026
Holdings
120
positions
Whale Score
61
61
tracked
Activity
no data
changes this Q
AI Analysis · Q1 2026
Comprehensive Analysis of Eversept Partners, LP SEC 13F Filing
Portfolio Overview

Eversept Partners, LP manages a concentrated portfolio totaling $934.89 million across 54 holdings as of the report date September 30, 2025. The firm manages a highly specialized fund that underwent significant transformation during the quarter, evidenced by a 14.0% decrease in total portfolio value (down from $1.09 billion) and a massive turnover in holdings. The portfolio is characterized by hi...

Key Holdings

The portfolio is dominated by mid-to-large cap healthcare names, with United Therapeutics Corp (UTHR) emerging as the flagship position, comprising 12.08% of the portfolio ($112.94M). This represents a significant bet on the company, bolstered by a massive capital infusion of $95.88 million (+353.8%) during the quarter.

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight
01
UTHR
UNITED THERAPEUTICS CORP DEL
$157M264K8.3%
02
QQQ
INVESCO QQQ TR
$138M239K7.3%
03
ABVX
ABIVAX SA
$104M934K5.5%
04
GSK
GSK PLC
$99M1.8M5.2%
05
VERA
VERA THERAPEUTICS INC
$87M2.2M4.6%
06
NTRA
NATERA INC
$77M385K4.1%
07
SPY
STATE STR SPDR S&P 500 ETF T
$70M107K3.7%
08
SNDX
SYNDAX PHARMACEUTICALS INC
$67M2.9M3.6%
09
CLDX
CELLDEX THERAPEUTICS INC NEW
$57M1.8M3.0%
10
PCVX
VAXCYTE INC
$54M924K2.8%

Filing history

2026Q1Mar 31
$1.9B 4.4%
120 positionsView →
2025Q4Dec 31
$2.0B 112.3%
107 positionsView →
2025Q3Sep 30
$935M 14.0%
54 positionsView →
2025Q2Jun 30
$1.1B 10.4%
68 positionsLocked
2025Q1Mar 31
$985M 12.6%
57 positionsLocked
2024Q4Dec 31
$1.1B 22.8%
65 positionsLocked
2024Q3Sep 30
$1.5B 0.0%
67 positionsLocked
2024Q2Jun 30
$1.5B 2.6%
74 positionsLocked
2024Q1Mar 31
$1.5B 31.7%
70 positionsLocked
2023Q4Dec 31
$1.1B 3.7%
57 positionsLocked
2023Q3Sep 30
$1.2B 1.2%
69 positionsLocked
2023Q2Jun 30
$1.2B 16.6%
71 positionsLocked
Showing 12 of 34